购物车
- 全部删除
- 您的购物车当前为空
MMPP 是一种新型 VEGFR2 抑制剂,具有抗炎活性和潜在的抗癌活性,抑制STAT3 ,可通过 VEGFR2/AKT/ERK/NF-kappaB 通路抑制血管生成,可用于缓解心肌损伤。
为众多的药物研发团队赋能,
让新药发现更简单!
MMPP 是一种新型 VEGFR2 抑制剂,具有抗炎活性和潜在的抗癌活性,抑制STAT3 ,可通过 VEGFR2/AKT/ERK/NF-kappaB 通路抑制血管生成,可用于缓解心肌损伤。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,780 | 现货 | |
5 mg | ¥ 4,480 | 现货 | |
10 mg | ¥ 6,380 | 现货 | |
25 mg | ¥ 9,620 | 现货 | |
50 mg | ¥ 12,900 | 现货 |
产品描述 | MMPP is a novel VEGFR2 inhibitor with anti-inflammatory and potential anticancer activity, inhibits STAT3, inhibits angiogenesis via VEGFR2/AKT/ERK/NF-kappaB pathway, and can be used to alleviate myocardial injury. |
分子量 | 270.32 |
分子式 | C17H18O3 |
CAS No. | 1895957-18-2 |
Smiles | C(=C/CC1=CC=C(OC)C=C1)\C2=CC(OC)=C(O)C=C2 |
密度 | 1.137 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||||||||||||
溶解度信息 | 5% DMSO+40% PEG300+5% Tween 80+50% Saline: 2.5 mg/mL (9.25 mM), Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. Ethanol: 27.03 mg/mL (100 mM), Sonication is recommended. DMSO: 50 mg/mL (184.9 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容